Related references
Note: Only part of the references are listed.Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head
Gauri R. Varadhachary et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: The Mayo Clinic experience (1975-2005)
Michele M. Corsini et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins hospital
Joseph M. Herman et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head
Douglas B. Evans et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram
Rebekah R. White et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial
Francoise Mornex et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer
CH Crane et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2006)
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma
MS Talamonti et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Radiochemotherapy in the management of pancreatic cancer - Part I: Neoadjuvant treatment
F Mornex et al.
SEMINARS IN RADIATION ONCOLOGY (2005)
Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer
RR White et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
JP Neoptolemos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Curative resection is the single most important factor determing outcome in patients with pancreatic adenocarcinoma
M Wagner et al.
BRITISH JOURNAL OF SURGERY (2004)
Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma
V Moutardier et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: Toxicities histologic response rates, and event-free outcome
PWT Pisters et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial
JP Neoptolemos et al.
ANNALS OF SURGERY (2001)
Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas
JF Pingpank et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2001)
Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer
VK Mehta et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Resected adenocarcinoma of the pancreas - 616 patients: Results, outcomes, and prognostic indicators
TA Sohn et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2000)